Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Public “Experiment” With OTC Zocor Challenged In Lancet Editorial

This article was originally published in The Tan Sheet

Executive Summary

Editors of the UK medical journal The Lancet suggest that a surveillance system be put in place to monitor use of OTC simvastatin in an editorial appearing in the journal's May 22 issue

You may also be interested in...



OTC Simvastatin In UK Will Provide Boon For Rx Counterparts – Lancet Letter

An Rx-to-OTC switch of 10 mg simvastatin is "not guaranteed" to take pressure off government health expenditures in the UK, according to a letter to the editor in the July 31 Lancet

OTC Simvastatin In UK Will Provide Boon For Rx Counterparts – Lancet Letter

An Rx-to-OTC switch of 10 mg simvastatin is "not guaranteed" to take pressure off government health expenditures in the UK, according to a letter to the editor in the July 31 Lancet

OTC Simvastatin In UK Will Provide Boon For Rx Counterparts – Lancet Letter

An Rx-to-OTC switch of 10 mg simvastatin is "not guaranteed" to take pressure off government health expenditures in the UK, according to a letter to the editor in the July 31 Lancet

Topics

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel